Summary
Acute myeloid leukaemia (AML) is a rapidly progressing haematopoietic malignancy, which is caused by diverse genetic aberrations. It is one of the most common myeloid malignancies with poor prognosis: the 5-year survival rate is only 19% for AML patients in Europe. The...
More information & hyperlinks
| Web resources: | https://www.bric.ku.dk/research/helin_group/ |
Search
Organisations
- Not specified